Johnson & Johnson today announced 12-month pilot-phase data from the OMNY-AF study, evaluating the investigational OMNYPULSE Platform for the treatment of symptomatic paroxysmal atrial fibrillation ...

Aspirus will host a free atrial fibrillation seminar on Feb. 11 in Wausau to explain symptoms, risks, and treatment options.

Background Mechanical compression from the ascending aorta on the left atrial anterior wall (LAAW) can cause low voltage ...

The V Foundation for Cancer Research today announced Brandi Williams Broome as its Chief Executive Officer, effective March 16. Broome steps into the role following Clark Kinlin, who has served as ...

On January 16, 2026, the U.S. Supreme Court announced its intent to hear the case of Hikma v. Amarin. This case follows the landmark GSK v. Teva ...

Drinking coffee can increase lifespan and decrease risk of type 2 diabetes, liver disease, cardiovascular disease, ...

United Regional is expanding its heart services with new technology and new providers.

Global Intracardiac Echocardiography Market OverviewThe global intracardiac echocardiography (ICE) market is projected to grow at a CAGR of approximately 10% over the forecast period. This growth is ...

Aims The obesity paradox has been described in different cardiovascular conditions. Data on the association between obesity and outcomes in patients with Takotsubo syndrome (TTS) are lacking. The aim ...

Atrial fibrillation, or A-fib, is becoming more common, but doctors say treatments are improving. The condition is a ...

New research from CU Anschutz scientists suggests that staying physically active after heart rhythm treatment may ...

New international research project AF-B-STEP will for the first time systematically assess how much time individuals spend in ...